Arunaksharan Narayanankutty

Dr. Arunaksharan Narayanankutty

PG and Research Department of Zoology, St. Joseph's College (Autonomous), Devagiri, Calicut, Kerala, International
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Current Drug Targets
Verified
Journal Article
Closed access
Arunaksharan NarayanankuttyArunaksharan Narayanankutty
Arunaksharan Narayanankutty
Background: Phosphoinositide 3-kinase (PI3Ks) is a member of intracellular lipid kinases and involved in the regulation of cellular proliferation, differentiation and survival. Overexpression of the PI3K/Akt/mTOR signalling has been reported in various forms of cancers, especially in colorectal cancers (CRC). Due to their significant roles in the initiation and progression events of colorectal cancer, they are recognized as a striking therapeutic target. Objective: The present review is aimed to provide a detailed outline on the role of PI3K/Akt/mTOR pathway in the initiation and progression events of colorectal cancers as well as its function in drug resistance. Further, the role of PI3K/Akt/mTOR inhibitors alone and in combination with other chemotherapeutic drugs, in alleviating colorectal cancer is also discussed. The review contains preclinical and clinical evidence as well as patent literature of the pathway inhibitors which are natural and synthetic in origin. Methods: The data were obtained from PubMed/Medline databases, Scopus and Google patent literature. Results: PI3K/Akt/mTOR signalling is an important event in colorectal carcinogenesis. In addition, it plays significant roles in acquiring drug resistance as well as metastatic initiation events of CRCs. Several small molecules of natural and synthetic origin have been found to be potent inhibitors of CRCs by effectively downregulating the pathway. Data from various clinical studies also support these pathway inhibitors and several among them are patented. Conclusion: Inhibitors of the PI3K/mTOR pathway have been successful for the treatment of primary and metastatic colorectal cancers, rendering the pathway as a promising clinical cancer therapeutic target.

30 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
NZNawal K. Z.AlFadhly
Nawal K. Z.AlFadhly
Nawfal Abdulameer AlhelfiNawfal Abdulameer Alhelfi
Nawfal Abdulameer Alhelfi
Ammar AltemimiAmmar Altemimi
Ammar Altemimi
Deepak Kumar VermaDeepak Kumar Verma
Deepak Kumar Verma
Francesco CacciolaFrancesco Cacciola
Francesco Cacciola
Arunaksharan NarayanankuttyArunaksharan Narayanankutty
Arunaksharan Narayanankutty
Spirulina is a kind of blue-green algae (BGA) that is multicellular, filamentous, and prokaryotic. It is also known as a cyanobacterium. It is classified within the phylum known as blue-green algae. Despite the fact that it includes a high concentration of nutrients, such as proteins, vitamins, minerals, and fatty acids—in particular, the necessary omega-3 fatty acids and omega-6 fatty acids—the percentage of total fat and cholesterol that can be found in these algae is substantially lower when compared to other food sources. This is the case even if the percentage of total fat that can be found in these algae is also significantly lower. In addition to this, spirulina has a high concentration of bioactive compounds, such as phenols, phycocyanin pigment, and polysaccharides, which all take part in a number of biological activities, such as antioxidant and anti-inflammatory activity. As a result of this, spirulina has found its way into the formulation of a great number of medicinal foods, functional foods, and nutritional supplements. Therefore, this article makes an effort to shed light on spirulina, its nutritional value as a result of its chemical composition, and its applications to some food product formulations, such as dairy products, snacks, cookies, and pasta, that are necessary at an industrial level in the food industry all over the world. In addition, this article supports the idea of incorporating it into the food sector, both from a nutritional and health perspective, as it offers numerous advantages.

17 September 2019 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
Arunaksharan NarayanankuttyArunaksharan Narayanankutty
Arunaksharan Narayanankutty
JJJoice Tom Job
Joice Tom Job
VNVinayak Narayanankutty
Vinayak Narayanankutty
Glutathione (GSH or reduced glutathione) is a tripeptide of gamma-Glutamyl-cysteinylglycine and the predominant intracellular antioxidant in many organisms including humans. GSH and associated enzymes are controlled by a transcription factor-nuclear factor-2 related erythroid factor-2 (Nrf2). In cellular milieu, GSH protects the cells essentially against a wide variety of free radicals including reactive oxygen species, lipid hydroperoxides, xenobiotic toxicants, and heavy metals. It has two forms, the reduced form or reduced glutathione (GSH) and oxidized form (GSSG), where two GSH moieties combine by sulfhydryl bonds. Glutathione peroxidase (GPx) and glutathione-s-transferase (GST) essentially perform the detoxification reactions using GSH, converting it into GSSG. Glutathione reductase (GR) operates the salvage pathway by converting GSSG to GSH with the expense of NADPH and restores the cellular GSH pool. Hence, GSH and GSH-dependent enzymes are necessary for maintaining the normal redox balance in the body and help in cell survival under stress conditions. In addition, GST removes various carcinogenic compounds offering a chemopreventive property, whereas the GSH system plays a significant role in regulating the cellular survival by offering redox stability in a variety of cancers including prostate, lung, breast, and colon cancer. Studies have also indicated that GSH inhibitors, such as buthionine sulfoximine, improve the chemo-sensitivity in cancer cells. In addition, GSH and dependent enzymes provide a survival advantage for cancer cells against chemotherapeutic drugs and radiotherapy.

1 October 2018 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
Arunaksharan NarayanankuttyArunaksharan Narayanankutty
Arunaksharan Narayanankutty
SISoorya Parathodi Illam
Soorya Parathodi Illam
ARAchuthan C. Raghavamenon
Achuthan C. Raghavamenon

26 April 2017 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
SISoorya Parathodi Illam
Soorya Parathodi Illam
Arunaksharan NarayanankuttyArunaksharan Narayanankutty
Arunaksharan Narayanankutty
ARAchuthan C. Raghavamenon
Achuthan C. Raghavamenon
Virgin coconut oil (VCO), extracted from the fresh coconut kernel, is a food supplement enriched with medium chain saturated fatty acids and polyphenolic antioxidants. It is reported to have several health benefits including lipid lowering, antioxidant and anti-inflammatory activities. The pharmacological benefits of VCO have been attributed to its polyphenol content (VCOP), the mechanistic basis of which is less explored. Liquid chromatography/mass spectroscopy (LC/MS) analysis of VCOP documented the presence of gallic acid, ferulic acid (FA), quercetin, methyl catechin, dihydrokaempferol and myricetin glycoside. Pre-treatment of VCOP at different concentrations (25–100 μg/mL) significantly reduced the H2O2 and 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH) induced cell death in HCT-15 cells. Giving further insight to its mechanistic basis, oxidative stress induced alterations in glutathione (GSH) levels and activities of GR (Glutathione–Reductase), GPx (Glutathione–Peroxidase), GST (Glutathione-S-Transferase) and catalase (CAT) were restored to near-normal by VCOP, concomitantly reducing lipid peroxidation. The efficacy of VCOP was similar to that of Trolox and FA added in culture. The study thus suggests that VCOP protects cells from pro-oxidant insults by modulating cellular antioxidant status.

27 September 2016 in Plant Foods for Human Nutrition
Verified
Journal Article
Closed access
PDF file
DSDevi Lekshmi Sheela
Devi Lekshmi Sheela
PNPuthiyaveetil Abdulla Nazeem
Puthiyaveetil Abdulla Nazeem
Arunaksharan NarayanankuttyArunaksharan Narayanankutty
Arunaksharan Narayanankutty
JMJeksy Jos Manalil
Jeksy Jos Manalil
ARAchuthan C. Raghavamenon
Achuthan C. Raghavamenon